Dialysis News and Research

Latest Dialysis News and Research

Fresenius Medical Care to sell $500 million and €300 million senior notes

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced its intention to sell US$500 million of senior unsecured notes due 2021 issued by Fresenius Medical Care US Finance, Inc. and €300 million of senior unsecured notes due 2021 issued by FMC Finance VII S.A..

21 Jan 2011

NMDP selects Velos to supply new Product Fulfillment and CDR System

The National Marrow Donor Program announced today that it has selected Velos, a leading California health care software provider, to supply its new Product Fulfillment and Clinical Data Repository System.

20 Jan 2011

Post Acute Medical plans to expand Warm Springs Rehabilitation System with two new San Antonio hospitals

Post Acute Medical today announced plans to expand the Warm Springs Rehabilitation System with two new hospitals in San Antonio.

20 Jan 2011

Hotspur announces successful completion of GPSCath Catheter in peripheral angioplasty surgery

Hotspur Technologies, announced today that Dr. Greg Sampognaro, Interventional Cardiologist at P & S Surgical Hospital in Monroe, Louisiana, successfully completed the first use of the GPSCath Balloon Dilatation Catheter in an intervention to treat a blocked peripheral artery.

18 Jan 2011

Home dialysis as effective as hospital dialysis for patients with kidney transplant failure

Patients who must return to dialysis after a kidney transplant failure survive just as well on home dialysis as hospital dialysis, but few choose that option, according to new research by Dr. Jeffrey Perl, a nephrologist at St. Michael's Hospital.

14 Jan 2011

14 foods that deliver research-documented benefits to health

With the start of a new year, many of us resolve to better our habits by trying to incorporate more nutritious foods into our diets. An article in the January issue of Food Technology magazine lists 14 foods that deliver research-documented benefits to health.

14 Jan 2011

Kidney transplant failure patients can opt for home-based dialysis therapy

According to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology, despite complications, these patients can choose to undergo dialysis in the comfort of their own homes.

14 Jan 2011

Patients on dialysis may face risk of death from atrial fibrillation: Study

The abnormal heart rhythm, atrial fibrillation, is increasingly common in patients on dialysis and is linked to a sharp rise in death, in an already at-risk population, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

14 Jan 2011

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Merck today announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S. Food and Drug Administration (FDA). The Company is also moving forward as planned with regulatory filings in countries outside the United States.

12 Jan 2011

Emotional progress of patients treated with dialysis in the Basque Country Autonomous Community: Study

Patients who have to undergo dialysis see their lives inevitably affected by the treatment. Despite medical advances, the quality of life perceived by these kidney patients has improved very little, although it varies from person to person. Basing this as her starting point, Dr Begoña Ruiz de Alegría studied the emotional progress of patients treated with dialysis (hospitalised haemodialysis treatment and domiciliary peritoneal dialysis) in the Basque Country Autonomous Community.

11 Jan 2011

First commercial deployment of Hotspur GPSCath Balloon Dilatation Catheter

Hotspur Technologies, Inc. announced today that Dr. Bruce Lin, M.D., and Dr. Stephen Liu, M.D., Interventional Radiologists at Lifelink Interventional Center in Modesto, California, performed the first commercial deployment of the company's GPSCath™ Balloon Dilatation Catheter.

11 Jan 2011

U.S. District Court grants injunction for Sensipar patents

A U.S. District Court in Delaware today granted an injunction preventing Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals Industries Ltd., and Barr Laboratories, Inc. from commercializing generic versions of Amgen's Sensipar® (cinacalcet) until expiration of the drug's U.S. patents.

10 Jan 2011

PCPs and kidney specialists favor collaborative care for progressive chronic kidney disease

Most primary care physicians (PCPs) and kidney specialists favor collaborative care for a patient with progressive chronic kidney disease (CKD), but their preferences on how and when to collaborate differ, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). PCPs and kidney specialists need to partner more effectively to optimize care for patients with CKD.

7 Jan 2011

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).

5 Jan 2011

Fresenius Medical Care to acquire Euromedic's dialysis service business

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced the signing of a purchase agreement to acquire International Dialysis Centers ("IDC"), Euromedic International's ("Euromedic") dialysis service business.

4 Jan 2011

Patients unresponsive to anti-anemia drug have higher risk of cardiovascular disease, death

Patients with diabetes, kidney disease and anemia who don't respond to treatment with an anti-anemia drug have a higher risk of cardiovascular disease or death, researchers at UT Southwestern Medical Center have found.

28 Dec 2010

MCP-1 protein may contribute to failure of AV fistulas created for vascular access in dialysis patients

A protein implicated in the development of vascular diseases may also contribute to the failure of arteriovenous (AV) fistulas created for vascular access in dialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

23 Dec 2010

Renal Advantage, Liberty Dialysis announce deal closure

Renal Advantage and Liberty Dialysis, which last month agreed to combine to form the third largest provider of dialysis services in the U.S., today announced that they have closed their deal. The transaction – terms of which were not disclosed – was completed on December 17, 2010. The combined organization has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.

23 Dec 2010

Liberty Dialysis and Renal Advantage to form the third largest dialysis provider in the U.S.

Liberty Dialysis and Renal Advantage today announced that the deal to form the 3rd largest dialysis provider in the U.S. has closed. The transaction was completed on December 17, 2010. The new company has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.

23 Dec 2010

FDA approves Novartis' Amturnide for treatment of high blood pressure

Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. Amturnide combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).

23 Dec 2010

Dialysis News and Research

Latest Dialysis News and Research

Fresenius Medical Care to sell $500 million and €300 million senior notes

NMDP selects Velos to supply new Product Fulfillment and CDR System

Post Acute Medical plans to expand Warm Springs Rehabilitation System with two new San Antonio hospitals

Hotspur announces successful completion of GPSCath Catheter in peripheral angioplasty surgery

Home dialysis as effective as hospital dialysis for patients with kidney transplant failure

14 foods that deliver research-documented benefits to health

Kidney transplant failure patients can opt for home-based dialysis therapy

Patients on dialysis may face risk of death from atrial fibrillation: Study

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Emotional progress of patients treated with dialysis in the Basque Country Autonomous Community: Study

First commercial deployment of Hotspur GPSCath Balloon Dilatation Catheter

U.S. District Court grants injunction for Sensipar patents

PCPs and kidney specialists favor collaborative care for progressive chronic kidney disease

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Fresenius Medical Care to acquire Euromedic's dialysis service business

Patients unresponsive to anti-anemia drug have higher risk of cardiovascular disease, death

MCP-1 protein may contribute to failure of AV fistulas created for vascular access in dialysis patients

Renal Advantage, Liberty Dialysis announce deal closure

Liberty Dialysis and Renal Advantage to form the third largest dialysis provider in the U.S.

FDA approves Novartis' Amturnide for treatment of high blood pressure

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Dialysis News and Research

Latest Dialysis News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in